Pharman Capsules Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 10.00 K
- Company Age 42 Year, 7 Months
- Last Filing with ROC 31 Mar 2019
- Satisfied Charges ₹ 3.87 M
About Pharman Capsules
Pharman Capsules Pvt Ltd (PCPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 July 1982 and has a history of 42 years and seven months. Its registered office is in Na, Gujarat.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 10.00 K .
The company has closed loans amounting to ₹3.87 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Chhotabhai Patel and Kalpesh Patel serve as directors at the Company.
Company Details
-
LocationNa, Gujarat
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231GJ1982PTC005318
-
Company No.
005318
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Jul 1982
-
Date of AGM
14 Aug 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Pharman Capsules?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chhotabhai Patel
|
Director | 01-Dec-1984 | Current |
|
Kalpesh Patel
|
Director | 10-Oct-2018 | Current |
Financial Performance of Pharman Capsules.
Enhance accessibility to Pharman Capsules's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharman Capsules?
Unlock access to Pharman Capsules's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0
₹3.87 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.39 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 May 1994 | State Bank Of India | ₹0.55 M | Satisfied |
| 26 Jul 1990 | State Bank Of India | ₹0.50 M | Satisfied |
| 17 Oct 1987 | State Bank Of India | ₹0.45 M | Satisfied |
| 02 May 1985 | State Bank Of India | ₹2.37 M | Satisfied |
How Many Employees Work at Pharman Capsules?
Unlock and access historical data on people associated with Pharman Capsules, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharman Capsules, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharman Capsules's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.